Navigation

Andrea Carmine Belin, Ph.D.

Carmine Belin List of Publications

Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jönsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlmann T, Anvret M, Olson L.

NURR1 mutations in cases of schizophrenia and manic-depressive disorder.

Am J Med Genet 96(6): 808-813, 2000

Buervenich S, Sydow O, Carmine A, Zhang Z, Anvret M, Olson L.

Alcohol dehydrogenase alleles in Parkinson's disease.

Mov Disord 15(5): 813-818, 2000

Carmine A, Buervenich S, Sydow O, Anvret M, Olson L.

Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease.

Mov Disord 17(4):764-766, 2001

Carmine A, Chheda MG, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Anvret M, Buervenich S, Olson L.

Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits.

Psychiatr Genet 13(1): 23-28, 2003

Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L.

NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia and personality traits.

Am J Med Genet. 120B(1):51-57, 2003

Galter D, Carmine A, Buervenich S, Duester G, Olson L.

Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain.

Eur J Biochem 270: 1316-1326, 2003

Werme M, Hermanson E, Carmine A, Buervenich S, Zetterström RH, Thorén P, Ögren SO, Olson L, Perlmann T, Brené S.

Decreased ethanol preference and wheel running in Nurr1-deficient mice.

Eur J Neurosci 17: 2418-2424, 2003

Håkansson A, Melke J, Westberg L, Shahabi HN, Buervenich S, Carmine A, Klingborg K, Grundell MB, Schulhof B, Holmberg B, Ahlberg J, Eriksson E, Sydow O, Olson L, Johnels B, Nissbrandt H.

Lack of association between the BDNF Val66Met polymorphism and Parkinson's disease in a Swedish population.

Ann Neurol 53(6): 823, 2003

Galter D, Buervenich S, Carmine A, Anvret M, Olson L.

ALDH1 mRNA: Presence in human dopamine neurons, decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.

Neurobiol Dis 14(3): 637-647, 2003

Carmine A.

On Parkinson's disease and Schizophrenia - Case control studies, cellular localization and modelling of candidate genes.

Ph.D. Thesis, Karolinska Institutet, December 2003

Westberg L, Håkansson A, Melke J, Shahabi HN, Nilsson S, Buervenich S, Carmine A, Ahlberg J, Grundell MB, Schulhof B, Klingborg K, Holmberg B, Sydow O, Olson L, Johnels EB, Eriksson E, Nissbrandt H.

Association between the estrogen receptor beta gene and age-of-onset of Parkinson's disease.

Psychoneuroendocrinology 29(8): 993-998, 2004

Buervenich S, Carmine A, Galter D, Shahabi HN, Johnels B, Holmberg B, Ahlberg J, Nissbrandt H, Eerola J, Hellström O, Tienari PJ, Matsuura T, Ashizawa T, Wüllner U, Klockgether T, Zimprich A, Gasser T, Hanson M, Singleton A, McMahon FJ, Anvret M, Sydow O, Olson L.

A rare truncating mutation in ADH1C (G78stop) shows significant association with Parkinson's disease in a large international sample.

Arch Neurol 62(1): 74-78, 2005

Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B, Sydow S, Olson L, Johnels B, Eriksson E, Nissbrandt H.

Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease.

Am J Med Genet B Neuropsychiatr Genet 133(1):88-92, 2005

Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B, Sydow O, Olson L, Johnels B, Eriksson E, Nissbrandt H.

Investigation of genes coding for inflammatory components in Parkinson's disease.

Mov Disord 20(5):569-573, 2005

Westerlund M, Galter D, Carmine A, Olson L.

Tissue- and species-specific expression patterns of class I, III, and IV Adh and Aldh1 mRNAs in rodent embryos.

Cell Tissue Res 322(2): 227-236, 2005

Galter D, Westerlund M, Belin AC, Olson L.

DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents.

Physiol Behav 92(1-2): 46-53, 2007

Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L.

LRRK2 expression linked to dopamine-innervated areas.

Ann Neurol 59(4): 714-719, 2006

Carmine Belin A, Westerlund M, Sydow O, Lundströmer K, Håkansson A, Nissbrandt H, Olson L and Galter D.

Leucine-Rich Repeat Kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.

Mov Disord 21(10): 1731-1734, 2006

Håkansson A, Bergman O, Chrapkowska C, Westberg L, Belin AC, Sydow O, Johnels B, Olson L, Holmberg B, Nissbrandt H.

Cyclooxygenase-2 polymorphisms in Parkinson's disease.

Am J Med Genet B Neuropsychiatr Genet 144B(3): 367-369, 2007

Elbaz A, Nelson LM, Payami H, Ioannidis JPA, Fiske BL, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, Mellick GD, Nutt JG, Ritz B, Samii A,Tanner CM, Van Broeckhoven C, Van Den Eeden SK, Wirdefeldt K, Zabetian CP, Dehem M, Montimurro JS, Southwick A, Myers RM, Trikalinos TA.

Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.

Lancet Neurology 5(11): 917-923, 2006

Carmine Belin A, Westerlund M, Bergman O, Nissbrandt H, Lind C, Sydow O, Galter D.

S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.

Parkinsonism Relat Disord 13(5): 295-298, 2007

Westerlund M, Belin AC, Olson L and Galter D.

High and complementary expression patterns of alcohol and aldehyde dehydrogenases in the gastrointestinal tract, implications for Parkinson's disease.

FEBS J 274(5): 1212-1223, 2007

Belin AC, Björk BF, Westerlund M, Galter D, Sydow O, Lind C, Pernold K, Håkansson A, Nissbrandt H, Graff C, Olson L.

Association study of two previously reported genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease.

Neuroscience Letters 420(3): 257-262, 2007

Håkansson A, Belin AC, Stiller C, Sydow O, Johnels B, Olson L, Holmberg B, Nissbrandt H.

Investigation of genes related to familial forms of Parkinson's disease - With focus on the Parkin gene.

Parkinsonism Relat Disord 14(6): 520-522, 2008

Westerlund M, Belin AC, Anvret A, Bickford P, Olson L and Galter D.

Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease.

Neuroscience 152(2): 429-436, 2008

Belin AC, Westerlund M.

Parkinson's disease: A genetic perspective.

FEBS J 275(7): 1377-1383, 2008

Westerlund M, Belin AC, Anvret A, Håkansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D.

Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.

FASEB J 22(10): 3509-3514, 2008

Westerlund M, Belin AC, Olson L, Galter D.

Expression of multi-drug resistance 1 mRNA in human and rodent tissues; reduced levels in Parkinson patients.

Cell Tissue Res 334(2): 179-185, 2008

Belin AC, Galter D.

S18Y, UCH-L1 and Parkinson's Disease.

European Neurological Review 3(2): 41-44, 2009

Westerlund M, Belin AC, Anvret A, Håkansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D.

Association of a polymorphism in the ABCB1 gene with Parkinson's disease.

Parkinsonism Relat Disord 15(6): 422-424, 2009

Bergman O, Håkansson A, Westberg L, Carmine Belin A, Sydow O, Olson L, Holmberg B, Fratiglioni L, Bäckman L, Eriksson E, Nissbrandt H.

Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?

J Neural Transm 116(3): 333-338, 2009

Niazi Shahabi H, Westberg L, Melke J, Håkansson A, Carmine Belin A, Sydow O, Olson L, Holmberg B, Nissbrandt H.

Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.

J Neural Transm 116(5): 567-573, 2009

Bergman O, Håkansson A, Westberg L, Nordenström K, Carmine Belin A, Sydow O, Olson L, Holmberg B, Eriksson E, Nissbrandt H.

PITX3 polymorphism is associated with early onset Parkinson's disease.

Neurobiol Aging 31(1): 114-117, 2010

Evangelou E, Maraganore DM, Annesi G, Brighina L, Brice A, Elbaz A, Ferrarese C, Hadjigeorgiou GM, Krueger R, Lambert JC, Lesage S, Markopoulou K, Mellick GD, Meeus B, Pedersen NL, Quattrone A, Van Broeckhoven C, Sharma M, Silburn PA, Tan EK, Wirdefeldt K, Ioannidis JP,

Genetic Epidemiology of Parkinson's Disease (GEOPD) Consortium*. Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. *Principal investigator of GEOPD in Stockholm.

Am J Med Genet B Neuropsychiatr Genet 153B(1): 220-228, 2010

Anvret A, Ran C, Westerlund M, Thelander AC, Sydow O, Lind C, Håkansson A, Nissbrandt H, Galter D, Belin A.

Possible involvement of a mitochondrial translation initiation factor 3 variant causing decreased mRNA levels in Parkinson's disease.

Parkinson's Dis 2010:491751, 2010

Anvret A, Westerlund M, Sydow O, Willows T, Lind C, Galter D, Carmine Belin AC.

Variations of the CAG trinucleotide repeat in DNA polymerase gamma (POLG1) is associated with Parkinson's disease in Sweden.

Neuroscience Letters 485: 117120, 2010

Belin AC, Westerlund M, Anvret A, Lindqvist E, Pernold K, Ögren SO, Duester G, Galter D.

Modeling Parkinson's disease genetics: altered function of the dopamine system in Adh4 knockout mice.

Behav Brain Res 217(2): 439-445, 2011

Westerlund M, Behbahani H, Gellhaar S, Forsell C, Carmine Belin A, Anvret A, Zettergren A, Nissbrandt H, Lind C, Sydow O, Graff C, Olson L, Ankarcrona M, Galter D.

Altered enzymatic activity and allele frequency of Omi/HtrA2 in Alzheimer's Disease.

FASEB J 25(4): 1345-1352, 2011. Epub 2010 Dec 16.

Anvret A, Blackinton JG, Ran C, Westerlund M, Galter D, Sydow O, Lind C, Håkansson A, Nissbrandt H, Carmine Belin A.

DJ-1 mutations are rare in a Swedish Parkinson cohort.

Open Neurol J 5: 8-11, 2011

Ran C, Westerlund M, Anvret A, Willows T, Sydow O, Galter D, Carmine Belin A.

Genetic studies of the Protein Kinase AKT1 in Parkinson's disease.

Accepted in Neuroscience Letters.

Last modified by: Ida Engqvist 2011-07-26
Neurovetenskap